AstraZeneca Puts Up $4.1B To Take Over Diabetes Drug JV
AstraZeneca PLC will pay up to $4.1 billion to take over rival Bristol-Myers Squibb's stake in a joint venture aimed at developing diabetes treatments, streamlining the business to better cash in...To view the full article, register now.
Already a subscriber? Click here to view full article